Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT

Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT

Introduction: Patients with atrial fibrillation frequently suffer from heart failure despite having a normal ejection fraction. There is no proven therapy to improve physical capacity and quality of life in patients with permanent atrial fibrillation with preserved cardiac contractility. Objective:...

Full description

Bibliographic Details
Main Authors: Eduard Shantsila, Farhan Shahid, Yongzhong Sun, Jonathan J Deeks, Ronnie Haynes, Melanie Calvert, James P Fisher, Paulus Kirchhof, Paramjit S Gill, Gregory YH Lip
Format: Article
Language:English
Published: NIHR Journals Library 2020-07-01
Series:Efficacy and Mechanism Evaluation
Subjects:
atrial fibrillation
heart failure
spironolactone
clinical trial
heart failure with preserved ejection fraction
Online Access:https://doi.org/10.3310/eme07040

Internet

https://doi.org/10.3310/eme07040

Similar Items